Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Journal of Nuclear Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00181760PMID 8404956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A prospective study of the use of111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake

  2005cited by this paper
• Gamma camera emission tomography using radiolabelled antibodies

  2004cited by this paper
• Does immunoscintigraphy serve clinical needs effectively? Is there a future for radioimmunotherapy?

  2004cited by this paper
• Immunoscintigraphy with antimelanoma monoclonal. Antibodies in the diagnosis of choroidal melanomas

  1995cited by this paper
• Intraoperative gamma detection probe with presurgical antibody imaging in colon cancer.

  1991cited by this paper
• Diagnostic evaluation of 111In and 99mTc radiolabelled monoclonal antibodies in ovarian and colorectal cancer: correlations with surgery.

  1991cited by this paper
• Radiolabelled monoclonal antibodies in oncology. I. Technical aspects.

  1991cited by this paper
• 99mTc radioimmunoscintigraphy of colorectal cancer.

  1990cited by this paper
• Reduction-mediated technetium-99m labeling of monoclonal antibodies.

  1990cited by this paper
• 99Tcm‐labelled anti‐CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results

  1989cited by this paper
• Three approaches to radiolabeling antibodies with 99mTc.

  1989cited by this paper
• A Brief Guide to the Practice of Radioimmunoscintigraphy and Radioimmunotherapy in Cancer

  1989cited by this paper
• Quo vadis radioimmune imaging.

  1989cited by this paper
• Prospects for radioimmunoimaging and radioimmunotherapy in oncology?

  1988cited by this paper
• Experience with Iodine-123 Labeled Antibodies

  1988cited by this paper
• Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy.

  1988cited by this paper
• A NOVEL APPROACH TO 99M TC-LABELED MONOCLONAL ANTIBODIES

  1987cited by this paper
• Monoclonal antibodies to human colorectal epithelium: Markers for differentiation and tumour characterization

  1987cited by this paper
• Radioimmunoscintigraphy in tumour identification.

  1987cited by this paper
• Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.

  1986cited by this paper
• Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoembryonic antigen monoclonal antibody.

  1986cited by this paper
• Immunoscintigraphy of colon carcinoma.

  1984cited by this paper
• Immunoscintigraphy with 123I, 99mTc and 111In-labelled F(ab')2 fragments of monoclonal antibodies to a human high molecular weight-melanoma associated antigen.

  1984cited by this paper
• The detection of ovarian cancer using 123J monoclonal antibody.

  1984cited by this paper
• Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours.

  1982cited by this paper
• Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen.

  1982cited by this paper
• Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation.

  1980cited by this paper
• Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen.

  1980cited by this paper
• The classification of cancer of the rectum

  1980cited by this paper
• The adenoma-carcinoma sequence.

  1978cited by this paper

• CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas

  2014cites this paper
• Recent trends in antibody-based oncologic imaging.

  2012cites this paper
• Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA

  2009cites this paper
• CEA-targeted monoclonal antibody therapy in colorectal cancer

  2009cites this paper
• Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosis

  2009cites this paper
• A novel approach for identification of tumor‐associated antigens expressed on the surface of tumor cells

  2007cites this paper
• Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, magnetic resonance imaging, and radioimmunoscintigraphy

  2006cites this paper
• Indium-Ill Activity Concentration in Tissue Samples After Intravenous Injection of Indium-111-DTPA-D-Phe-l-Octreotide

  2006cites this paper
• Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer

  2004cites this paper
• Imaging of metastases to the liver

  2004cites this paper
• Radioimmunoscintigraphy with Tc‐99m‐labelled SM3 in differentiating malignant from benign adnexal masses

  2003cites this paper
• Evaluation of a transgenic mouse model for anti-human CEA radioimmunotherapeutics.

  2002cites this paper
• Targeting of Human Breast Cancer by a Bispecific Antibody Directed against Two Tumour-Associated Antigens: ErbB-2 and Carcinoembryonic Antigen

  2002cites this paper
• The value of immunoscintigraphy in the detection of recurrent colorectal cancer

  2001cites this paper
• The impact of new technology on surgery for colorectal cancer.

  2001cites this paper
• Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors

  2001cites this paper
• Radioimmunoscintigraphy in patients with ovarian cancer.

  2001cites this paper
• Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.

  2000cites this paper
• Efficacy of immunoscintigraphy for detection of lymph node metastases.

  2000cites this paper
• Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma.

  2000cites this paper
• Monoclonal antibody MAb-170 for immunoscintigraphic detection of ovarian tumors.

  1999cites this paper
• Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigen

  1999cites this paper
• Effect of radioimmunoscintigraphy in management of recurrent colorectal cancer

  1999cites this paper
• Radioimmunodetection: technical problems and methods of improvement.

  1999cites this paper
• Evaluation of an anti-carcinoembryonic monoclonal antibody suitable for immunoscintigraphy.

  1999cites this paper
• Preoperative staging of rectal carcinoma

  1999cites this paper
• Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer

  1998cites this paper
• Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.

  1998cites this paper
• Tumour identification using radiopharmaceuticals.

  1997cites this paper
• Towards the goal of cancer-specific imaging and therapy.

  1997cites this paper
• Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer

  1996cites this paper
• Antibody-based immunotherapeutic strategies in colorectal cancer.

  1996cites this paper
• Radiolabeled monoclonal antibodies in diagnosis and therapy of cancer. Summary and perspectives.

  1996cites this paper
• Immunoscintigraphy: Importance for researchers and patients.

  1996cites this paper
• Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation

  1996cites this paper
• Effect of Circulating Antigen on Immunoscintigraphy of Ovarian Cancer Patients Using Anti‐CA125 Monoclonal Antibody

  1996cites this paper
• Tumor imaging with monoclonal antibodies.

  1995cites this paper
• Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.

  1995cites this paper
• Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide.

  1995cites this paper
• Radioimmunoscintigraphy of ovarian tumours with technetium-99m labelled monoclonal antibody-170: first clinical experiences

  1995cites this paper
• A cross-linked monoclonal antibody fragment for improved tumor targeting.

  1995cites this paper
• Planar, SPET and three‐dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In‐B72.3 (Oncoscint CR‐OV): Effect of administered activity

  1994cites this paper
• An epitope on carcinoembryonic antigen defined by the clinically relevant antibody PR1A3.

  1994cites this paper